These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 3031934)

  • 1. Effect of naloxone on PTH and calcitonin secretion and 25-hydroxy-vitamin D concentration in chronic renal failure.
    Grzeszczak W; Kokot F; Duława J
    Acta Med Pol; 1986; 27(1-2):67-75. PubMed ID: 3031934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of naloxone on parathyroid hormone and calcitonin secretion and 25-hydroxyvitamin D levels in patients with acute renal failure].
    Grzeszczak W; Kokot F; Duława J
    Pol Tyg Lek; 1986 Jan; 41(2):38-41. PubMed ID: 3010260
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulsatile-secretion of parathyroid hormone in patients with chronic renal failure.
    de Francisco AL; Amado JA; Cotorruelo JG; González M; de Castro SS; Canga E; de Bonis E; Ruiz JC; Arias M; Gonzalez-Macías J
    Clin Nephrol; 1993 Apr; 39(4):224-8. PubMed ID: 8491053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The parathyroids and calcitonin. Study of its clinical physiology. II. Thyrocalcitonin and vitamin D; metabolic actions; study of its physiopathology].
    Garrido B; Jiménez JA; Damiano A; Betancort P; Macías A
    Rev Iber Endocrinol; 1971; 18(103):49-82. PubMed ID: 4931027
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of naloxone on corticotropin (ACTH) and somatotropin (HGH) secretion in patients with chronic renal failure].
    Grzeszczak W; Kokot F; Duława J
    Pol Arch Med Wewn; 1985 Sep; 74(3):181-8. PubMed ID: 2853865
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of naloxone on prolactin secretion in patients with acute and chronic renal failure.
    Grzeszczak W; Kokot F; Dulawa J
    Clin Nephrol; 1984 Jan; 21(1):47-9. PubMed ID: 6705273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naloxone administration on endocrine abnormalities in chronic renal failure.
    Grzeszczak W; Kokot F; Duława J
    Am J Nephrol; 1987; 7(2):93-100. PubMed ID: 3037907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levels of plasma 1,25-dihydroxyvitamin D and parameters of phospho-calcium metabolism in children with non-dialyzed chronic renal failure].
    Loras B; Parchoux B; Durr F
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():755-60. PubMed ID: 6897703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ratio of parathyroid hormone to 1,25-dihydroxycholecalciferol in early renal failure.
    Lucas PA; Brown RC; Woodhead JS; Coles GA
    Kidney Int Suppl; 1983 Dec; 16():S171-4. PubMed ID: 6588249
    [No Abstract]   [Full Text] [Related]  

  • 12. Parathyroid gland metabolism.
    Raisz LG
    Arch Intern Med; 1969 Oct; 124(4):389-96. PubMed ID: 4898544
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis.
    Baradaran A; Nasri H
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):344-50. PubMed ID: 16970254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium metabolism in post-menopausal women.
    Mendoza C; Ortega E; Ruiz E; Carreras A; Osorio C
    Rev Esp Fisiol; 1985 Dec; 41(4):447-50. PubMed ID: 3938042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
    Lucas PA; Woodhead JS; Brown RC
    Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
    Magliola L; Anast CS; Forte LR
    Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of naloxone on endocrine abnormalities in acute renal failure.
    Grzeszczak W; Kokot F; Wiecek A
    Acta Med Pol; 1988; 29(1-2):1-15. PubMed ID: 2855691
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of 25(OH) vitamin D (calcidiol) deficiency at time of renal transplantation: a prospective study.
    Sadlier DM; Magee CC
    Clin Transplant; 2007; 21(6):683-8. PubMed ID: 17988259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of opioid receptor blockade with naloxone on vasopressin secretion in patients with transplanted kidney].
    Grzeszczak W; Zukowska-Szczechowska E; Kokot F
    Pol Arch Med Wewn; 1992 Oct; 88(4):219-24. PubMed ID: 1336854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct feed-back regulation of PTH-secretion by 1,25-dihydroxyvitamin D3 in renal failure: a controlled trial.
    Madsen S; Olgaard K; Ladefoged J
    Proc Eur Dial Transplant Assoc; 1980; 17():557-62. PubMed ID: 6894641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.